Servet Özden HACIVELİOĞLU, Tayfun ÇOK, Halil Tayfun BAĞIŞ, Ebru TARIM

First trimester maternal serum PAPP-A levels and macrosomia in nondiabetic mothers

To determine whether or not there is a relationship between first-trimester maternal serum pregnancy-associated placental protein (PAPP-A) levels and fetal macrosomia in nondiabetic mothers. Materials and methods: In this study, 63 consecutive term macrosomic neonates (Group 1) (birth weight >= 4000 g) and 100 consecutive appropriate-for-gestational-age (AGA) term neonates (Group 2) were included. Transabdominal ultrasound examinations were performed to diagnose any major fetal defects and to measure crown-rump length (CRL) and fetal nuchal translucency (NT) thickness. Blood samples were drawn from each woman in order to obtain fasting blood glucose, PAPP-A, and free beta-human chorionic gonadotropin (beta-hCG) levels. Ultrasound measurements of the fetal biparietal diameter, abdominal circumference, and femur length were obtained at 29-34 weeks of gestation. Results: The two groups were similar with respect to maternal age, parity, and gestational age in the first trimester. There were no significant differences between the groups in terms of the mean plasma levels of PAPP-A, free beta-HCG (as MoM values), mean CRL, and NT measurements. First-trimester PAPP-A levels were not correlated with birth weight (r = -0.116, P = 0.146), maternal age (r = 0.137, P = 0.089), maternal body mass index (BMI) in the first trimester (r = -0.037, P = 0.641) or at delivery (r = 0.042, P = 0.620), fasting blood glucose in the first trimester (r = -0.019, P = 0.816), macrosomia (r = -0.092, P = 0.249), or the occurrence of male sex (r = -0.074, P = 0.358) by the Pearson and Spearman correlations. In addition, first-trimester PAPP-A levels were not correlated with ultrasonographic measurements at 29-34 weeks of gestation. Conclusion: Although PAPP-A may promote fetal growth and development through metabolic and differentiation pathways, it seems that there is no relationship between PAPP-A levels and macrosomia.

Anahtar Kelimeler:

Key words: PAPP-A, macrosomia, first-trimester screening

First trimester maternal serum PAPP-A levels and macrosomia in nondiabetic mothers

Keywords:

Key words: PAPP-A, macrosomia, first-trimester screening,

PDF

___

Giudice LC, Conover CA, Bale L, Faessen GH, Ilg K, Sun I et al. Identifi cation and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. Th e Journal of Clinical Endocrinology & Metabolism 2002; 87: 2359-66.
Boldt HB, Conover CA. PAPP-A: A local regulator of IGF bioavailability through cleavage of IGFBPs. Growth Hormone & IGF Research 2007; 17: 10-18. 3. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Decreased fi rst trimester PAPP-A is predictor of adverse pregnancy outcome. Prenat Diagn 2002; 22: 778-82. 4. Kniss DA, Shubert PJ, Zimmerman PD, Landon MB, Gabbe SG. Insulin-like growth factors: their regulation of glucose and amino acid transport in placental trophoblasts isolated from fi rst-trimester chorionic villi. J Reprod Med 1994; 39: 249-56.
Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH et al. First-trimester maternal serum PAPP-A and free beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (Th e FASTER Trial). Am J Obstet Gynecol 2004; 191: 1446-51.
Boyd ME, Usher RH, McLean FH. Fetal macrosomia: Prediction, risks, proposed management. Obstet Gynecol 1983; 61: 715-722.
Gross SJ, Shime J, Farine D. Shoulder dystocia: Predictors and outcome. A fi ve-year review. Am J Obstet Gynecol 1987; 156: 334-336.
Divon MY. Diagnosis and management of macrosomia. Fetal Diagn Th er 1998; 13 (Suppl): 31.
Mondanlou HD, Dorchester WL, Th orosian A, Freeman RK. Macrosomia: maternal, fetal, and neonatal implications. Obstet Gynecol 1980; 55: 420-424.
Gluckman PD, Liggins GC. Regulation of fetal growth. In: Beard RW, Nathanielsz PW, editors. Fetal Physiology and Medicine: Th e Basis of Perinatology. 2nd ed. Marcel Dekker: New York; 1984. p.511-558.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-346.
Hadlock FP, Harrist RB, Carpenter RJ, Deter RL, Park SK. Sonographic estimation of fetal weight. Radiology 1984; 150: 535-540.
Hadlock FP, Harrist RB, Sharman RS, Deter RL, Rossavik UK. Estimation of fetal weight with the use of head, body, and femur measurements: a prospective study. Am J Obstet Gynecol 1985; 151: 333-337.
Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768-773.
Akinbi, HT, Gerdes, JS. Macrosomic infants of nondiabetic mothers and elevated C-peptide levels in cord blood. J Pediatr 1995; 127: 481-5.
Peterson SE, Simhan HN. First-trimester pregnancy-associated plasma protein A and subsequent abnormalities of fetal growth. Am J Obstet Gynecol 2008; 198: e43-5.
Canini S, Prefumo F, Pastorino D, Crocetti L, Affl itto C, Venturini P. Association between birth weight and fi rst- trimester free b–human chorionic gonadotropin and pregnancy-associated plasma protein A. Fertil Steril 2008; 89: 174-8.
Habayeb O, Daemen A, Timmerman D, De Moor B, Hackett GA, Bourne T et al. Th e relationship between fi rst-trimester fetal growth, pregnancy-associated plasma protein A levels and birthweight. Prenat Diagn 2010; Jul 26 (published electronically in advance of printing).
Smith GCS, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of PAPP-A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87: 1762-7.
Roberts CT, Owens JA, Sferruzzi-Perri AN. Distinct actions of insulin-like growth factors (IGFs) on placental development and fetal growth: lessons from mice and guinea pigs. Placenta 2008; 22: S42-S47.
Carter AM, Kingston MJ, Han KK, Mazzuca DM, Nygard K, Han VK. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs. J Endocrinol 2005; 184: 179-89.
Constancia M, Hemberger M, Hughes J, Dean W, Ferguson- Smith A, Fundele R. Placental-specifi c IGF-II is a major modulator of placental and fetal growth. Nature 2002; 417: 945-8.
Leung T, Chan LW, Leung TN, Fung TY, Sahota DS, Lau TK. First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters. Ultrasound Obstet Gynecol. 2006; 27: 156-61.
Grissa O, Yessoufou A, Mrisak I, Hichami A, Amoussou- Guenou D, Grissa A et al. Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia. BMC Pregnancy Childbirth 2010; 10: 7.